BRASILIA - A Covid vaccine developed by China’s Sinovac has been found to be 50.4% effective in Brazilian clinical trials, showing the jab is significantly less effective than previous data suggested.

Indonesia, Turkey and Singapore are among the countries to have placed orders for the vaccine.

It works by using dead viral particles to expose the body's immune system to the virus without risking a serious disease response.